Imaging Technology
Pros and cons of FDG PET in breast cancer follow-up reviewed
Published in Women's Health Weekly, September 30th, 2004
P. Lind and colleagues, LKH Klagenfurt, PET CT Center, wrote: "18F-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) has been evaluated in breast cancer for the characterization of primary tumors, lymph node staging, and the follow-up of patients after surgery, chemotherapy, and/or external radiotherapy.
"In contrast to both the low sensitivity and moderate specificity of FDG PET in the initial detection and characterization of breast cancer and the low...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
MRI more accurate for detecting disease due to BRCA gene mutation - Epidemiology
New report maps women's health in the United States - Osteoporosis
Teriparatide called "breakthrough" in treatment of severe osteoporosis - Reproductive Health
Lack of funding, HIV epidemic threaten Cairo Conference goals - Risk Factors
Two studies look at fitness vs. fatness as indicators of diabetes, CHD in women - Addiction Medicine
Nicotine therapy more effective for men than women, study finds - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
